Cagrilintide

Cagrilintide is a long-acting amylin analogue, and it matters in incretin research precisely because amylin is a separate pathway from GLP-1. Native amylin is co-secreted with insulin but aggregates readily, which makes it impractical to work with; cagrilintide is engineered for solubility and a much longer half-life while keeping activity at both the calcitonin and amylin receptor families.

That is why it appears most often as the second half of a combination rather than on its own. Supplied lyophilised per vial.

Store sealed at -20 C, reconstitute with bacteriostatic water, refrigerate the working solution and keep it out of light. Studied together with semaglutide, and stocked as the fixed combination CagriSema.

Purity data on our lab reports page. For laboratory research use only.

Add to cart

Sold strictly for in-vitro laboratory and research use only. Not for human or veterinary consumption.